Clinical implications. The role of selective prescribing in the increased risk of VTE associated with third-generation oral contraceptives

By Jamin C.   Benifla J-L.   Madelenat P.  

Human Reproduction Update, Vol. 5, Iss. 6, 1999-12 ,pp. : 664-671

Oxford University Press

Access to resources Recommend Favorite

Fotemustine: A Third-Generation Nitrosourea for the Treatment of Recurrent Malignant Gliomas

By Beauchesne Patrick  

Cancers, Vol. 4, Iss. 1, 2012-02 ,pp. : 77-87

MDPI

Access to resources Recommend Favorite

The recent saga of cardiovascular disease and safety of oral contraceptives

By Edwards R.  

Human Reproduction Update, Vol. 5, Iss. 6, 1999-12 ,pp. : 565-620

Oxford University Press

Access to resources Recommend Favorite

Conclusions: the relative safety of modern oral contraceptives

By Cohen J.  

Human Reproduction Update, Vol. 5, Iss. 6, 1999-12 ,pp. : 756-771

Oxford University Press

Access to resources Recommend Favorite

Combined oral contraceptives in the treatment of polycystic ovary syndrome

By Vrbíková J.  

Human Reproduction Update, Vol. 11, Iss. 3, 2005-05 ,pp. : 277-291

Oxford University Press

Access to resources Recommend Favorite